Orange Book product · Brand (NDA)
TREXIMET
NAPROXEN SODIUM; SUMATRIPTAN SUCCINATE
At a glance
May 14, 2015
Approved
Brand (NDA)
Application
Not listed
TE code
2
Listed patents
Key dates
Approval
FDA approval date of this drug product.
May 14, 2015
11 yr 3 mo ago
Patent 7332183 expires
Listed drug product patent expiration.
Oct 02, 2025
9 mo ago
Patent 7332183*PED expires
Listed listed patent expiration.
Apr 02, 2026
3 mo ago
Today
Pharmaceutical detail
Active ingredient
NAPROXEN SODIUM; SUMATRIPTAN SUCCINATE
Strength
60MG;EQ 10MG BASE
Dosage form
TABLET
Route
ORAL
TE code
Not listed
Application
NDA 021926
Product number
002
Marketing status
DISCN
Reference listed drug (RLD)
Yes
Reference standard (RS)
No
Active-ingredient family
View full familyThis is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.
Listed patents (2)
| Patent | Expires | In | Type |
|---|---|---|---|
| 7332183 | Oct 02, 2025 | 9 mo ago | ProductU-1719 |
| 7332183*PED | Apr 02, 2026 | 3 mo ago |
